|
FNDC3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.936400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.326000E-02 |
| Normal-vs-Stage2 |
9.799800E-03 |
| Normal-vs-Stage3 |
2.222300E-04 |
| Normal-vs-Stage4 |
5.776600E-04 |
| Stage1-vs-Stage2 |
2.497800E-01 |
| Stage1-vs-Stage3 |
2.155700E-02 |
| Stage1-vs-Stage4 |
5.300100E-02 |
| Stage2-vs-Stage3 |
6.163000E-01 |
| Stage2-vs-Stage4 |
5.416000E-01 |
| Stage3-vs-Stage4 |
8.295800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.839100E-03 |
| Normal-vs-AfricanAmerican |
8.087800E-01 |
| Normal-vs-Asian |
4.757800E-02 |
| Caucasian-vs-AfricanAmerican |
1.923590E-02 |
| Caucasian-vs-Asian |
6.425600E-01 |
| AfricanAmerican-vs-Asian |
8.197800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.805700E-04 |
| Normal-vs-Female |
1.829720E-02 |
| Male-vs-Female |
6.293500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.930200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.461570E-03 |
| Normal-vs-Age(61-80Yrs) |
9.53820000000327E-05 |
| Normal-vs-Age(81-100Yrs) |
5.594200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.063800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.898200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.495000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.155000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.739800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.296600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.761900E-02 |
| Classical-VS-Follicular |
2.287000E-01 |
| Classical-VS-Other |
2.003600E-01 |
| Classical-VS-Normal |
3.230200E-02 |
| Tall-VS-Follicular |
3.656800E-01 |
| Tall-VS-Other |
6.307800E-01 |
| Tall-VS-Normal |
1.421490E-03 |
| Follicular-VS-Other |
4.426000E-01 |
| Follicular-VS-Normal |
1.115960E-02 |
| Other-VS-Normal |
2.118100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.299910E-03 |
| Normal-vs-N1 |
1.550130E-02 |
| N0-vs-N1 |
8.325800E-01 |
|
|
